Last Updated: 15 Sep 2024
Executive Summary
National Research Corp (NRC) is a leading provider of analytics and information that enhance patient and employee experiences in the healthcare industry. With a strong financial performance and a market capitalization of $522.78 million, NRC offers investors a compelling investment opportunity.
Company Overview
Headquartered in Lincoln, Nebraska, NRC specializes in measuring and improving patient and employee satisfaction. The company's solutions include patient experience surveys, employee engagement studies, and data analytics that enable healthcare organizations to identify areas for improvement and enhance overall outcomes.
Fundamental Analysis
Revenue: NRC's revenue reached $146.28 million in the trailing twelve months (TTM), with a modest decline of 0.032% year-over-year.
Earnings: Diluted EPS stood at $1.19 in the TTM, reflecting a decline of 0.108% compared to the previous year.
Profitability: The company maintains a healthy profit margin of 0.2 and an operating margin of 0.253, indicating efficient operations.
Valuation: NRC trades at a trailing P/E ratio of 18.4, which is in line with industry peers. The company's price-to-sales ratio of 3.574 and price-to-book ratio of 12.83 suggest a fair valuation.
Technical Analysis
Moving Averages: NRC's 50-day moving average is at $22.68, while the 200-day moving average is at $32.45. The current price of $21.9 is below both moving averages, indicating a potential downtrend.
Support and Resistance: Key support levels lie at $20.41 (52-week low) and $22.68 (50-day moving average). Resistance levels are at $26.59 (200-day moving average) and $46.59 (52-week high).
Short Term Outlook
In the short term, NRC may face headwinds due to the overall market volatility and potential economic slowdown. The company's revenue and earnings growth could be impacted, leading to further price declines.
Long Term Outlook
The long-term outlook for NRC remains positive. The healthcare industry is expected to continue growing, and NRC's solutions are well-positioned to meet the evolving needs of healthcare organizations. The company's strong financial position and focus on innovation should support its long-term growth prospects.
Analyst Recommendations
Currently, there are no analyst recommendations available for NRC. However, based on the fundamental and technical analysis, a "Hold" rating seems appropriate at this time. Investors should monitor the company's upcoming earnings reports and economic conditions before making any investment decisions.
